141 related articles for article (PubMed ID: 30548484)
1. Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma.
Smith JD; Birkeland AC; Rosko AJ; Hoesli RC; Foltin SK; Swiecicki P; Mierzwa M; Chinn SB; Shuman AG; Malloy KM; Casper KA; McLean SA; Wolf GT; Bradford CR; Prince ME; Brenner JC; Spector ME
Head Neck; 2019 Feb; 41(2):423-428. PubMed ID: 30548484
[TBL] [Abstract][Full Text] [Related]
2. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
[TBL] [Abstract][Full Text] [Related]
3. Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma.
Bednarek K; Kiwerska K; Szaumkessel M; Bodnar M; Kostrzewska-Poczekaj M; Marszalek A; Janiszewska J; Bartochowska A; Jackowska J; Wierzbicka M; Grenman R; Szyfter K; Giefing M; Jarmuz-Szymczak M
Tumour Biol; 2016 Aug; 37(8):11115-26. PubMed ID: 26912061
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain.
Wu CP; Zhou L; Gong HL; Du HD; Tian J; Sun S; Li JY
Cancer Lett; 2014 Jan; 342(1):92-103. PubMed ID: 24001612
[TBL] [Abstract][Full Text] [Related]
5. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
[TBL] [Abstract][Full Text] [Related]
6. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma.
Foteinou E; Kontos CK; Giotakis AI; Scorilas A
Biol Chem; 2014 Sep; 395(9):1051-62. PubMed ID: 24854539
[TBL] [Abstract][Full Text] [Related]
7. TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma.
Russo A; Corsale S; Agnese V; Macaluso M; Cascio S; Bruno L; Surmacz E; Dardanoni G; Valerio MR; Vieni S; Restivo S; Fulfaro F; Tomasino RM; Gebbia N; Bazan V
J Cell Physiol; 2006 Jan; 206(1):181-8. PubMed ID: 15965904
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
9. Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma.
Todorova TA; Jordanov SH; Stancheva GS; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
Pathol Oncol Res; 2015 Apr; 21(2):413-21. PubMed ID: 25149524
[TBL] [Abstract][Full Text] [Related]
10. Recurrent amplification in the 22q11 region in laryngeal squamous cell carcinoma results in overexpression of the CRKL but not the MAPK1 oncogene.
Kostrzewska-Poczekaj M; Giefing M; Jarmuz M; Brauze D; Pelinska K; Grenman R; Bartochowska A; Szyfter W; Szyfter K
Cancer Biomark; 2010-2011; 8(1):11-9. PubMed ID: 21896986
[TBL] [Abstract][Full Text] [Related]
11. [Investigation on recurrent-associated gene expression pattern of recurrent-laryngeal squamous cell carcinoma].
Wang B; Chen Y; Wen S; Xia L; Wang J; Huangfu H; Gong J; He X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jun; 17(6):339-41. PubMed ID: 14503368
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma.
Re M; Çeka A; Rubini C; Ferrante L; Zizzi A; Gioacchini FM; Tulli M; Spazzafumo L; Sellari-Franceschini S; Procopio AD; Olivieri F
Laryngoscope; 2015 Sep; 125(9):E306-12. PubMed ID: 26153151
[TBL] [Abstract][Full Text] [Related]
14. [Expression of astrocyte elevated gene-1 protein and its clinical significance in laryngeal squamous cell carcinoma].
Liu Y; Li G; Su ZW; Qiu YZ; Zhang X; Yu CY; Zhou XJ; Ren SL; Huang DH; Tian YQ
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):111-5. PubMed ID: 23710918
[TBL] [Abstract][Full Text] [Related]
15. Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma.
Manterola L; Aguirre P; Larrea E; Arestín M; Gaafar A; Elorriaga K; Goicoechea I; Armesto M; Fernández-Mercado M; Zabalza I; López-Duque JC; Larruskain E; Sistiaga JA; Landa M; Zabala A; Santaolalla F; Municio JA; Ispizua Á; García-Pedrero JM; Rodrigo JP; Lawrie CH
Sci Rep; 2018 Apr; 8(1):6613. PubMed ID: 29700339
[TBL] [Abstract][Full Text] [Related]
16. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma.
Shi Y; Gong HL; Zhou L; Tian J; Wang Y
ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):78-85. PubMed ID: 22354323
[TBL] [Abstract][Full Text] [Related]
17. Molecular differentiation of early and late stage laryngeal squamous cell carcinoma: an exploratory analysis.
Saglam O; Shah V; Worsham MJ
Diagn Mol Pathol; 2007 Dec; 16(4):218-21. PubMed ID: 18043285
[TBL] [Abstract][Full Text] [Related]
18. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
19. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI
Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007
[TBL] [Abstract][Full Text] [Related]
20. Nuclear expression of onco-suppressors nm23-H1 and maspin are associated with lower recurrence rate in laryngeal carcinoma.
Marioni G; Ottaviano G; de Filippis C; Fasanaro E; Randon B; Meneghesso S; Giacomelli L; Astolfi L; Blandamura S
Am J Otolaryngol; 2019; 40(2):224-229. PubMed ID: 30683471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
